Cargando…

Therapeutic Effects of Breviscapine in Cardiovascular Diseases: A Review

Breviscapine is a crude extract of several flavonoids of Erigeron breviscapus (Vant.) Hand.-Mazz., containing more than 85% of scutellarin, which has been traditionally used in China as an activating blood circulation medicine to improve cerebral blood supply. Accumulating evidence from various in v...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gao, Jialiang, Chen, Guang, He, Haoqiang, Liu, Chao, Xiong, Xingjiang, Li, Jun, Wang, Jie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2017
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5441392/ https://www.ncbi.nlm.nih.gov/pubmed/28588491 http://dx.doi.org/10.3389/fphar.2017.00289

Ejemplares similares

The Effects of Breviscapine Injection on Hypertension in Hypertension-Induced Renal Damage Patients: A Systematic Review and a Meta-Analysis
por: Wu, Lihua, et al.
Publicado: (2019)

Breviscapine remodels myocardial glucose and lipid metabolism by regulating serotonin to alleviate doxorubicin-induced cardiotoxicity
por: Li, Meng-Jiao, et al.
Publicado: (2022)

Breviscapine Injection Improves the Therapeutic Effect of Western Medicine on Angina Pectoris Patients
por: Wang, Chuan, et al.
Publicado: (2015)

Functional compounds of ginseng and ginseng-containing medicine for treating cardiovascular diseases
por: Liu, Lanchun, et al.
Publicado: (2022)

Regulatory Mechanisms of Baicalin in Cardiovascular Diseases: A Review
por: Xin, Laiyun, et al.
Publicado: (2020)

Panax notoginseng Saponins for Treating Coronary Artery Disease: A Functional and Mechanistic Overview
por: Duan, Lian, et al.
Publicado: (2017)

Exploring the “gene–protein–metabolite” network of coronary heart disease with phlegm and blood stasis syndrome by integrated multi-omics strategy
por: Yang, Guang, et al.
Publicado: (2022)

Breviscapine reverses doxorubicin resistance in breast cancer and its related mechanisms
por: Fu, Weijiang, et al.
Publicado: (2023)

The effect of auricular therapy on blood pressure: A systematic review and meta-analysis
por: Gao, JiaLiang, et al.
Publicado: (2019)

Nose-to-Brain Delivery by Nanosuspensions-Based in situ Gel for Breviscapine
por: Chen, Yingchong, et al.
Publicado: (2020)

Improving Breviscapine Oral Bioavailability by Preparing Nanosuspensions, Liposomes and Phospholipid Complexes
por: Song, Zilin, et al.
Publicado: (2021)

Breviscapine Ameliorates Fear Extinction and Anxiety in BALB/cJ Mice
por: Liang, Wei, et al.
Publicado: (2023)

Efficacy and Safety of Traditional Chinese Medicine in Coronavirus Disease 2019 (COVID-19): A Systematic Review and Meta-Analysis
por: Wang, Heping, et al.
Publicado: (2021)

Gut Microbiota: A Novel Regulator of Cardiovascular Disease and Key Factor in the Therapeutic Effects of Flavonoids
por: Li, Qinyu, et al.
Publicado: (2021)

Engineering yeast for the production of breviscapine by genomic analysis and synthetic biology approaches
por: Liu, Xiaonan, et al.
Publicado: (2018)

Therapeutic Effects of Wenxin Keli in Cardiovascular Diseases: An Experimental and Mechanism Overview
por: Tian, Guihua, et al.
Publicado: (2018)

Preparation, Characterization, and Evaluation of Breviscapine Nanosuspension and Its Freeze-Dried Powder
por: Zhang, Ting, et al.
Publicado: (2022)

Promising Antioxidative Effect of Berberine in Cardiovascular Diseases
por: An, Na, et al.
Publicado: (2022)

Identification of differentially expressed non-coding RNAs and mRNAs involved in Qi stagnation and blood stasis syndrome
por: Chen, Guang, et al.
Publicado: (2019)

Bioactive Ingredients in Chinese Herbal Medicines That Target Non-coding RNAs: Promising New Choices for Disease Treatment
por: Dong, Yan, et al.
Publicado: (2019)

Emodin in cardiovascular disease: The role and therapeutic potential
por: Guo, Yuanyuan, et al.
Publicado: (2022)

LncRNA MEG3: Potential stock for precision treatment of cardiovascular diseases
por: Li, Zining, et al.
Publicado: (2022)

Effect of breviscapine injection on clinical parameters in diabetic nephropathy: A meta-analysis of randomized controlled trials
por: Liu, Xiaodan, et al.
Publicado: (2016)

Effect of Crataegus Usage in Cardiovascular Disease Prevention: An Evidence-Based Approach
por: Wang, Jie, et al.
Publicado: (2013)

Breviscapine regulates the proliferation, migration, invasion, and apoptosis of colorectal cancer cells via the PI3K/AKT pathway
por: Niu, Pengfei, et al.
Publicado: (2023)

Therapeutic Potential of Ginsenosides as an Adjuvant Treatment for Diabetes
por: Bai, Litao, et al.
Publicado: (2018)

The Potential Therapeutic Application of Peptides and Peptidomimetics in Cardiovascular Disease
por: Recio, Carlota, et al.
Publicado: (2017)

A New Therapeutic Candidate for Cardiovascular Diseases: Berberine
por: Cai, Yun, et al.
Publicado: (2021)

Editorial: Efficacy and mechanism of herbal medicines and their functional compounds in preventing and treating cardiovascular diseases and cardiovascular disease risk factors
por: Meng, Tiantian, et al.
Publicado: (2023)

Combined Therapy of Hypertensive Nephropathy with Breviscapine Injection and Antihypertensive Drugs: A Systematic Review and a Meta-Analysis
por: Wu, Lihua, et al.
Publicado: (2018)

Therapeutic Effects of Traditional Chinese Medicine on Cardiovascular Diseases: the Central Role of Calcium Signaling
por: Li, Yuxin, et al.
Publicado: (2021)

Editorial: Inflammation in Cardiovascular Diseases: Role of the Endothelium and Emerging Therapeutics
por: Qin, Cheng Xue, et al.
Publicado: (2020)

Cardiovascular Effects of Salvianolic Acid B
por: Wang, Jie, et al.
Publicado: (2013)

Breviscapine reduces neuronal injury caused by traumatic brain injury insult: partly associated with suppression of interleukin-6 expression
por: Jiang, Ling, et al.
Publicado: (2017)

I(f) Channel as an Emerging Therapeutic Target for Cardiovascular Diseases: A Review of Current Evidence and Controversies
por: Mengesha, Hayelom G., et al.
Publicado: (2017)

Breviscapine alleviates NASH by inhibiting TGF‐β‐activated kinase 1‐dependent signaling
por: Lan, Tian, et al.
Publicado: (2021)

Determination of scutellarin in breviscapine preparations using quantitative proton nuclear magnetic resonance spectroscopy
por: Jiang, Zhenzuo, et al.
Publicado: (2016)

Hydrogen Sulfide (H(2)S)-Releasing Compounds: Therapeutic Potential in Cardiovascular Diseases
por: Zhang, Lei, et al.
Publicado: (2018)

Salvia miltiorrhiza in Treating Cardiovascular Diseases: A Review on Its Pharmacological and Clinical Applications
por: Ren, Jie, et al.
Publicado: (2019)

Protective effect of breviscapine in acute pulmonary embolism rats via regulation of MCP‐1 and IL‐13
por: Li, Zhenkun, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_19950skl4lua9s8itfhs6n7vdv